Adapting UK Biobank imaging for use in a routine memory clinic setting: The Oxford Brain Health Clinic

Autor: Ludovica Griffanti, Grace Gillis, M. Clare O'Donoghue, Jasmine Blane, Pieter M. Pretorius, Robert Mitchell, Nicola Aikin, Karen Lindsay, Jon Campbell, Juliet Semple, Fidel Alfaro-Almagro, Stephen M. Smith, Karla L. Miller, Lola Martos, Vanessa Raymont, Clare E. Mackay

Publikováno v: NeuroImage: Clinical, Vol 36, Iss , Pp 103273- (2022)

The Oxford Brain Health Clinic (BHC) is a joint clinical-research service that provides memory clinic patients and clinicians access to high-quality assessments not routinely available, including brain MRI aligned with the UK Biobank imaging study (U

Externí odkaz: https://doaj.org/article/a492c9e7a85948e1ba47c3d75ecde581

Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Autor: Netteke Schouten-van Meeteren, Katrin Scheinemann, Ranjeev Bhangoo, Pieter M. Pretorius, Gregory T. Armstrong, Daniel C. Bowers, Riccardo Haupt, W. Hamish B. Wallace, Kevin C. Oeffinger, Andrew W. Walter, Antony Ng, Michael M. Hawkins, Raja B. Khan, Helen Jenkinson, Jop C Teepen, Raoul C. Reulen, Leontien C. M. Kremer, Noah D. Sabin, Elaine Sugden, Renée L. Mulder, Melissa M. Hudson, Paul Klimo, Helena J H van der Pal, Zsila Sadighi, Cécile M. Ronckers, Roderick Skinner, Louis S. Constine, Nicole J. Ullrich, Lisanne C Verbruggen

Publikováno v: The Lancet Oncology. 22:e196-e206

Exposure to cranial radiotherapy is associated with an increased risk of subsequent CNS neoplasms among childhood, adolescent, and young adult (CAYA) cancer survivors. Surveillance for subsequent neoplasms can translate into early diagnoses and inter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cde9903f331946ab57aee53109949f9
https://doi.org/10.1016/s1470-2045(20)30688-4

P14.85 Impact of the neuro-radiologist and neuro-surgeon in contouring with the neuro-oncologist on local relapse rates for brain metastases treated with stereotactic radiosurgery

Autor: Robin Joseph, Maxwell Robinson, Pieter M. Pretorius, K Sayal, Sanjeeva Jeyaretna, Sriram Padmanaban, Clare Tunstall, R.A. Watson, Claire Hobbs

Publikováno v: Neuro Oncol

BACKGROUND The audit evaluates the value of MDT, including neuro-radiologist and neuro-surgeon, review of contouring carried out by a clinical oncologist in stereotactic radiosurgery (SRS). MATERIAL AND METHODS A sequential audit was conducted of all

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549f1855ff0a5d2d321d10e9639f6e62
https://europepmc.org/articles/PMC8427364/

Diffusion tractography for awake craniotomy: accuracy and factors affecting specificity

Autor: Puneet Plaha, Vasileios Apostolopoulos, Natalie L. Voets, Pieter M. Pretorius, Martin D Birch, Richard Stacey

Publikováno v: Journal of Neuro-Oncology

Introduction Despite evidence of correspondence with intraoperative stimulation, there remains limited data on MRI diffusion tractography (DT)’s sensitivity to predict morbidity after neurosurgical oncology treatment. Our aims were: (1) evaluate DT

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a2af9149bbc864d89f171115005a0cc
https://pubmed.ncbi.nlm.nih.gov/34196915

Genetic Severity Score predicts clinical phenotype in NF2

Autor: Pieter M. Pretorius, Sally Painter, Helen Tomkins, Beatrice Emmanouil, D. Gareth Evans, Allyson Parry, Dorothy Halliday, Samuel MacKeith

Publikováno v: Halliday, D, Emmanouil, B, Pretorius, P, MacKeith, S, Painter, S, Tomkins, H, Evans, D & Parry, A 2017, ' GENETIC SEVERITY SCORE PREDICTS CLINICAL PHENOTYPE IN NF2 ', Journal of Medical Genetics . https://doi.org/10.1136/jmedgenet-2017-104519
Journal of Medical Genetics

​Background The clinical severity of disease in neurofibromatosis type 2 (NF2) is variable. Patients affected with a constitutional truncating NF2 mutation have severe disease, while missense mutations or mosaic mutations present with a milder atte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e026b7e3316f672d1034994409a453f1
https://doi.org/10.1136/jmedgenet-2017-104519